Scientists hope the discovery will lead to new treatments for the disease More: UK researchers make new Alzheimer’s disease discovery Source: News
read moreAdding Kisquali to Faslodex resulted in an almost 30% reduction in risk of death compared to Faslodex alone More: Novartis’ Kisquali bests AZ’ Faslodex in breast cancer trial Source: News
read moreAmgen and UCB’s Evenity has been given the green light for postmenopausal women with severe osteoporosis to help prevent further fractures More: EU approves new osteoporosis treatment Source: News
read moreConservatives win a huge majority after a crushing defeat for Labour More: Boris Johnson remains UK prime minister Source: News
read moreStephen Hahn, an oncologist who served as chief medical officer for the MD Anderson Cancer Center, secured Senate confirmation Thursday as FDA commissioner. During the confirmation process, he told lawmakers he’d always follow science and data over politics, even as
read moreAs Bristol-Myers Squibb continues to search for bright spots in its eyebrow-raising Opdivo-chemo combo fail from June, it’s zeroing in on the population of squamous lung cancer patients who seemed to benefit. More: ESMO I-O: BMS zooms in on squamous
read more© 1994 - 2026 B.M. Pharmaceuticals